Your browser doesn't support javascript.
loading
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Bernard, Elsa; Nannya, Yasuhito; Hasserjian, Robert P; Devlin, Sean M; Tuechler, Heinz; Medina-Martinez, Juan S; Yoshizato, Tetsuichi; Shiozawa, Yusuke; Saiki, Ryunosuke; Malcovati, Luca; Levine, Max F; Arango, Juan E; Zhou, Yangyu; Solé, Francesc; Cargo, Catherine A; Haase, Detlef; Creignou, Maria; Germing, Ulrich; Zhang, Yanming; Gundem, Gunes; Sarian, Araxe; van de Loosdrecht, Arjan A; Jädersten, Martin; Tobiasson, Magnus; Kosmider, Olivier; Follo, Matilde Y; Thol, Felicitas; Pinheiro, Ronald F; Santini, Valeria; Kotsianidis, Ioannis; Boultwood, Jacqueline; Santos, Fabio P S; Schanz, Julie; Kasahara, Senji; Ishikawa, Takayuki; Tsurumi, Hisashi; Takaori-Kondo, Akifumi; Kiguchi, Toru; Polprasert, Chantana; Bennett, John M; Klimek, Virginia M; Savona, Michael R; Belickova, Monika; Ganster, Christina; Palomo, Laura; Sanz, Guillermo; Ades, Lionel; Della Porta, Matteo Giovanni; Elias, Harold K; Smith, Alexandra G.
Afiliación
  • Bernard E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nannya Y; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hasserjian RP; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Devlin SM; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Tuechler H; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Medina-Martinez JS; , Vienna, Austria.
  • Yoshizato T; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shiozawa Y; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Saiki R; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Malcovati L; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Levine MF; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Arango JE; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Zhou Y; Department of Hematology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
  • Solé F; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cargo CA; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Haase D; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Creignou M; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Germing U; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhang Y; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gundem G; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona, Spain.
  • Sarian A; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
  • van de Loosdrecht AA; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
  • Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Tobiasson M; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.
  • Kosmider O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Follo MY; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Thol F; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pinheiro RF; Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, the Netherlands.
  • Santini V; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Kotsianidis I; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Boultwood J; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris, France.
  • Santos FPS; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Schanz J; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School, Hannover, Germany.
  • Kasahara S; Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil.
  • Ishikawa T; MDS Unit, Hematology, AOU Careggi, University of Florence, Florence, Italy.
  • Tsurumi H; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
  • Takaori-Kondo A; Radcliffe Department of Medicine, University of Oxford and Oxford BRC Haematology Theme, Oxford, UK.
  • Kiguchi T; Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Polprasert C; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
  • Bennett JM; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
  • Klimek VM; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Savona MR; Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Belickova M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ganster C; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan.
  • Palomo L; Department of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Sanz G; Lab. Medicine and Pathology, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY, USA.
  • Ades L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Della Porta MG; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Elias HK; Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Smith AG; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
Nat Med ; 27(5): 927, 2021 May.
Article en En | MEDLINE | ID: mdl-33948021
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos